High-throughput solutions optimized for Kazakhstan's growing clinical and research infrastructure.
Kazakhstan is currently undergoing a significant transformation in its healthcare sector, driven by the "Health 2025" state program. As the economic powerhouse of Central Asia, there is a surging demand for localized, high-precision PCR diagnostic systems. From Almaty's bustling clinical hubs to the specialized research institutes in Nur-Sultan, the integration of Real-Time PCR (qPCR) and Automated Nucleic Acid Extraction is no longer a luxury but a fundamental requirement for public health safety.
Our role as a leading factory and supplier is to bridge the gap between advanced Chinese manufacturing efficiency and Kazakhstan's specific diagnostic challenges, including infectious disease monitoring, oncology markers, and agricultural genetic testing.
Scaling from standard qPCR to Digital PCR and Integrated Sample-to-Result Workflows.
Current focus is on replacing manual extraction with systems like the BNP-32, reducing human error and increasing throughput for Kazakhstan's primary laboratories.
Introduction of 5-6 color channel multiplexing in systems like the Gentier96E, allowing for the simultaneous detection of multiple pathogens from a single swab.
Integrating LIMS (Laboratory Information Management Systems) with PCR hardware to provide real-time epidemiological data across the Kazakhstan health network.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
The company's product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Shenzhen BioX Medical Co., Ltd. serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. The company also provides flexible OEM and ODM services for distributors, diagnostic companies, and healthcare organizations seeking customized molecular testing solutions.
As a critical supplier for Kazakhstan, we leverage the "One Belt One Road" logistics infrastructure to ensure that our PCR systems arrive safely and on time. Our supply chain is built on four pillars:
No middlemen. Direct communication with Shenzhen engineers for technical support.
Products meet CE and ISO standards, with documentation ready for Kazakhstan regulatory bodies.
OEM services allow for localizing software interfaces into Russian or Kazakh languages.
Virtual training and localized spare parts distribution for Central Asia.
Addressing common queries regarding PCR procurement and logistics in Kazakhstan.
Consult with our Kazakhstan account managers for specialized pricing and localized technical configurations.
BioX Medical
